AR029640A1 - Derivados de indolilpiperidinas que poseen actividad antihistaminica y antialergica, procesos para preparar dichos derivados y compuestos intermediarios utilizables en dicho proceso, composiciones formuladas con dichos derivados y uso de los derivados mencionados para el tratamiento del cuerpo human - Google Patents
Derivados de indolilpiperidinas que poseen actividad antihistaminica y antialergica, procesos para preparar dichos derivados y compuestos intermediarios utilizables en dicho proceso, composiciones formuladas con dichos derivados y uso de los derivados mencionados para el tratamiento del cuerpo humanInfo
- Publication number
- AR029640A1 AR029640A1 ARP000102755A ARP000102755A AR029640A1 AR 029640 A1 AR029640 A1 AR 029640A1 AR P000102755 A ARP000102755 A AR P000102755A AR P000102755 A ARP000102755 A AR P000102755A AR 029640 A1 AR029640 A1 AR 029640A1
- Authority
- AR
- Argentina
- Prior art keywords
- derivatives
- group
- alkoxy
- alkyl
- groups
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Pulmonology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Otolaryngology (AREA)
- Immunology (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Se describen y reivindican compuestos de la formula (1) en donde: A1 representa un grupo alquileno, alquilenoxi, alquilentio, alcanoil o hidroxialquileno; A2 representa un enlace sencillo, un grupo alquileno o alquenileno; W representa un enlace sencillo, un grupo fenilo o furanileno opcionalmente sustituido por uno o más átomos de halogeno, o grupos alcoxi y/o grupos alquilo; R1 representa un átomo de hidrogeno o un grupo alquilo, alquenilo, alquinilo, alcoxialquilo, alqueniloxialquilo, alquiniloxialquilo, alcoxi-alcoxialquilo, fenilalquilo en donde el anillo fenilo está opcionalmente sustituido por uno o más átomos de halogeno o grupos alquilo, alcoxi o arilalcoxi (preferentemente fenilalcoxi) o un grupo cicloalquilalquilo en donde el grupo cicloalquilo está opcionalmente sustituido por uno o más átomos de halogeno, grupos alquilo o grupos alcoxi; R2 representa un átomo de hidrogeno o halogeno, o un grupo alquilo o alcoxi; y R3 representa un grupo carboxilo o un grupo tetrazolilo; y sus sales son utiles por su actividad antihistamínica y antialérgica y pueden ser utilizados para el tratamiento de enfermedades alérgicas, incluidas asma bronquial, rinitis, conjuntivitis, dermatitis y urticarias.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES009901232A ES2165274B1 (es) | 1999-06-04 | 1999-06-04 | Nuevos derivados de indolilpiperidina como agentes antihistaminicos y antialergicos. |
Publications (1)
Publication Number | Publication Date |
---|---|
AR029640A1 true AR029640A1 (es) | 2003-07-10 |
Family
ID=8308707
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP000102755A AR029640A1 (es) | 1999-06-04 | 2000-06-02 | Derivados de indolilpiperidinas que poseen actividad antihistaminica y antialergica, procesos para preparar dichos derivados y compuestos intermediarios utilizables en dicho proceso, composiciones formuladas con dichos derivados y uso de los derivados mencionados para el tratamiento del cuerpo human |
Country Status (35)
Country | Link |
---|---|
US (1) | US6683096B2 (es) |
EP (1) | EP1183251B1 (es) |
JP (1) | JP2003501424A (es) |
KR (1) | KR100683454B1 (es) |
CN (1) | CN1191246C (es) |
AR (1) | AR029640A1 (es) |
AT (1) | ATE259362T1 (es) |
AU (1) | AU773164B2 (es) |
BG (1) | BG106168A (es) |
BR (1) | BR0011340A (es) |
CA (1) | CA2375985A1 (es) |
CO (1) | CO5180556A1 (es) |
CZ (1) | CZ20014334A3 (es) |
DE (1) | DE60008239T2 (es) |
DK (1) | DK1183251T3 (es) |
EE (1) | EE04717B1 (es) |
ES (2) | ES2165274B1 (es) |
HK (1) | HK1040990A1 (es) |
HU (1) | HUP0203320A3 (es) |
IL (1) | IL146629A0 (es) |
MX (1) | MXPA01012425A (es) |
MY (1) | MY127033A (es) |
NO (1) | NO20015897L (es) |
NZ (1) | NZ515649A (es) |
PE (1) | PE20010208A1 (es) |
PL (1) | PL196774B1 (es) |
PT (1) | PT1183251E (es) |
RU (1) | RU2246493C2 (es) |
SI (1) | SI1183251T1 (es) |
SK (1) | SK17042001A3 (es) |
TR (1) | TR200103490T2 (es) |
TW (1) | TWI226889B (es) |
UA (1) | UA72517C2 (es) |
WO (1) | WO2000075130A1 (es) |
ZA (1) | ZA200109676B (es) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU784813B2 (en) | 2000-01-17 | 2006-06-29 | Bayer Aktiengesellschaft | Substituted aryl ketones |
ES2172436B1 (es) | 2000-10-31 | 2004-01-16 | Almirall Prodesfarma Sa | Derivados de indolilpiperidina como agentes antihistaminicos y antialergicos. |
WO2002048105A2 (en) * | 2000-11-16 | 2002-06-20 | Wyeth | Aryloxy piperidinyl derivatives for the treatment of depression |
ES2201899B1 (es) * | 2002-04-01 | 2005-06-01 | Almirall Prodesfarma, S.A. | Derivados de la azaindolilpiperidina como agentes antihistaminicos y antialergicos. |
ES2201907B1 (es) * | 2002-05-29 | 2005-06-01 | Almirall Prodesfarma, S.A. | Nuevos derivados de indolilpiperidina como potentes agentes antihistaminicos y antialergicos. |
RU2382037C2 (ru) | 2003-11-17 | 2010-02-20 | Бёрингер Ингельхайм Интернациональ Гмбх | Новые пиперидинзамещенные индолы или их гетеропроизводные |
US20050245540A1 (en) * | 2003-12-09 | 2005-11-03 | Fujisawa Pharmaceutical Co., Ltd. | New methods |
US7678798B2 (en) * | 2004-04-13 | 2010-03-16 | Incyte Corporation | Piperazinylpiperidine derivatives as chemokine receptor antagonists |
CA2589565A1 (en) * | 2004-06-24 | 2006-01-05 | Incyte Corporation | Amido compounds and their use as pharmaceuticals |
NZ551603A (en) | 2004-06-24 | 2010-11-26 | Incyte Corp | N-substituted piperidines and their use as pharmaceuticals |
JP2008539267A (ja) * | 2005-04-26 | 2008-11-13 | ハイプニオン・インコーポレイテッド | ベンズイソオキサゾールピペリジン化合物及びその使用方法 |
US7759365B2 (en) | 2005-04-30 | 2010-07-20 | Boehringer Ingelheim International Gmbh | Piperidine-substituted indoles |
US20060275516A1 (en) * | 2005-06-02 | 2006-12-07 | Ram A N S | Compositions and methods for the treatment of allergic rhinitis |
WO2008030853A2 (en) * | 2006-09-06 | 2008-03-13 | Incyte Corporation | Combination therapy for human immunodeficiency virus infection |
JP5581055B2 (ja) * | 2006-10-27 | 2014-08-27 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ピペリジル−プロパン−チオールccr3モジュレーター |
UA100684C2 (uk) * | 2007-03-15 | 2013-01-25 | Новартіс Аг | Похідні бензилу та піридинілу як модулятори сигнального шляху hedgehog |
US20100041663A1 (en) | 2008-07-18 | 2010-02-18 | Novartis Ag | Organic Compounds as Smo Inhibitors |
CN101560179B (zh) * | 2009-05-25 | 2012-04-18 | 浙江大学 | 具有h3受体亲和能力的含氮吲哚衍生物和用途 |
CN101747321B (zh) * | 2009-12-22 | 2013-01-02 | 浙江大学 | 吲哚-3-苄胺衍生物及制备方法和用途 |
EP3040334A1 (en) * | 2014-12-29 | 2016-07-06 | Faes Farma, S.A. | New benzimidazole derivatives as antihistamine agents |
WO2023006893A1 (en) * | 2021-07-30 | 2023-02-02 | Confo Therapeutics N.V. | Compounds for the treatment of pain, in particular neuropathic pain, and/or other diseases or disorders that are associated with at2r and/or at2r mediated signaling |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4742057A (en) * | 1985-12-05 | 1988-05-03 | Fujisawa Pharmaceutical Co., Ltd. | Antiallergic thiazole compounds |
JPS63301881A (ja) * | 1987-06-01 | 1988-12-08 | Fujisawa Pharmaceut Co Ltd | インドリルピペリジン誘導体 |
DK733788A (da) * | 1988-01-14 | 1989-07-15 | Fujisawa Pharmaceutical Co | Indolylpiperidinderivater og fremgangsmaade til fremstilling deraf |
GB8900382D0 (en) * | 1989-01-09 | 1989-03-08 | Janssen Pharmaceutica Nv | 2-aminopyrimidinone derivatives |
PT626968E (pt) * | 1992-02-13 | 2002-03-28 | Merrell Pharma Inc | Derivados de piperidinilo tiaciclicos |
IT1271417B (it) * | 1993-10-15 | 1997-05-28 | Erregierre Ind Chim | Composti ad attivita' antiistaminica procedimento per la loro preperazione e composizioni farmaceutiche che li contengono. |
DE19500689A1 (de) | 1995-01-12 | 1996-07-18 | Merck Patent Gmbh | Indolpiperidin-Derivate |
DE19707628A1 (de) | 1997-02-26 | 1998-08-27 | Merck Patent Gmbh | Oxazolidinone |
AR013669A1 (es) * | 1997-10-07 | 2001-01-10 | Smithkline Beecham Corp | Compuestos y metodos |
AR028685A1 (es) * | 2000-06-14 | 2003-05-21 | Lundbeck & Co As H | Derivados de indol |
-
1999
- 1999-06-04 ES ES009901232A patent/ES2165274B1/es not_active Expired - Fee Related
-
2000
- 2000-05-31 PL PL353164A patent/PL196774B1/pl not_active IP Right Cessation
- 2000-05-31 EP EP00940296A patent/EP1183251B1/en not_active Expired - Lifetime
- 2000-05-31 EE EEP200100653A patent/EE04717B1/xx not_active IP Right Cessation
- 2000-05-31 PT PT00940296T patent/PT1183251E/pt unknown
- 2000-05-31 DK DK00940296T patent/DK1183251T3/da active
- 2000-05-31 SK SK1704-2001A patent/SK17042001A3/sk unknown
- 2000-05-31 MY MYPI20002439A patent/MY127033A/en unknown
- 2000-05-31 AT AT00940296T patent/ATE259362T1/de not_active IP Right Cessation
- 2000-05-31 CA CA002375985A patent/CA2375985A1/en not_active Abandoned
- 2000-05-31 BR BR0011340-9A patent/BR0011340A/pt not_active Application Discontinuation
- 2000-05-31 HU HU0203320A patent/HUP0203320A3/hu unknown
- 2000-05-31 AU AU55276/00A patent/AU773164B2/en not_active Ceased
- 2000-05-31 TR TR2001/03490T patent/TR200103490T2/xx unknown
- 2000-05-31 UA UA2001118222A patent/UA72517C2/uk unknown
- 2000-05-31 KR KR1020017015570A patent/KR100683454B1/ko not_active IP Right Cessation
- 2000-05-31 IL IL14662900A patent/IL146629A0/xx unknown
- 2000-05-31 RU RU2002100073/04A patent/RU2246493C2/ru not_active IP Right Cessation
- 2000-05-31 WO PCT/EP2000/005010 patent/WO2000075130A1/en active IP Right Grant
- 2000-05-31 PE PE2000000524A patent/PE20010208A1/es not_active Application Discontinuation
- 2000-05-31 SI SI200030323T patent/SI1183251T1/xx unknown
- 2000-05-31 DE DE2000608239 patent/DE60008239T2/de not_active Expired - Lifetime
- 2000-05-31 CN CNB008112819A patent/CN1191246C/zh not_active Expired - Fee Related
- 2000-05-31 NZ NZ515649A patent/NZ515649A/en unknown
- 2000-05-31 MX MXPA01012425A patent/MXPA01012425A/es unknown
- 2000-05-31 JP JP2001502413A patent/JP2003501424A/ja not_active Ceased
- 2000-05-31 CZ CZ20014334A patent/CZ20014334A3/cs unknown
- 2000-05-31 ES ES00940296T patent/ES2211559T3/es not_active Expired - Lifetime
- 2000-06-02 CO CO00041546A patent/CO5180556A1/es not_active Application Discontinuation
- 2000-06-02 TW TW089110816A patent/TWI226889B/zh not_active IP Right Cessation
- 2000-06-02 AR ARP000102755A patent/AR029640A1/es not_active Application Discontinuation
-
2001
- 2001-11-23 ZA ZA200109676A patent/ZA200109676B/en unknown
- 2001-12-03 NO NO20015897A patent/NO20015897L/no not_active Application Discontinuation
- 2001-12-03 BG BG106168A patent/BG106168A/bg unknown
- 2001-12-04 US US10/006,416 patent/US6683096B2/en not_active Expired - Fee Related
-
2002
- 2002-03-20 HK HK02102119.0A patent/HK1040990A1/zh unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR029640A1 (es) | Derivados de indolilpiperidinas que poseen actividad antihistaminica y antialergica, procesos para preparar dichos derivados y compuestos intermediarios utilizables en dicho proceso, composiciones formuladas con dichos derivados y uso de los derivados mencionados para el tratamiento del cuerpo human | |
AR047557A1 (es) | Compuestos derivados de piridazina y su uso como agentes terapeuticos | |
HUP0402508A2 (hu) | 1,2,3,4-Tetrahidro-izokinolin-származékok mint urotenzin II receptor antagonisták és a vegyületeket tartalmazó gyógyszerkészítmények | |
PE20230825A1 (es) | Inhibidores de kras triciclicos fusionados | |
ATE517908T1 (de) | Androstan-17-alpha-carbonat-derivate zur verwendung bei der behandlung allergischer und entzündlicher zustände | |
NO20061978L (no) | Imidazopyridinsubstituerte tropanderivater med CCR5-reseptorantagonist aktivitet for behandling av HIV og inflammasjon | |
PE20050664A1 (es) | Derivados de 1h-imidazo[4,5-c]quinolina | |
YU49443B (sh) | Derivati benzimidazola, postupci za njihovo pripremanje i primena tih derivata u medicinskoj terapiji, naročito za lečenje ili sprečavanje virusnih infekcija | |
PE20040512A1 (es) | Compuesto de pirazol-pirimidina anilina | |
AR041297A1 (es) | Derivados de 4-pirrolidino- fenil- bencil eter | |
AR032361A1 (es) | Derivados de androstano y sales y solvatos de los mismos, su uso para la fabricacion de medicamentos, composiciones farmaceuticas que comprenden tales compuestos, proceso para la preparacion de dichos compuestos, e intermediarios utiles en la preparacion de tales compuestos | |
ATE177095T1 (de) | Substituierte piperidine für die behandlung von allergischen krankheiten | |
PE20081362A1 (es) | DERIVADOS MORFOLINO PIRIMIDINA COMO INHIBIDORES DE mTOR QUINASA Y PI3K | |
UY28150A1 (es) | Agentes terapeuticos | |
NO20055977L (no) | Nye benzimidazolderivater | |
NO20063821L (no) | Kinolinderivater for anvendelse som mykobakterielle inhibitorer | |
MY129796A (en) | Novel anti-inflammatory androstane derivatives | |
TNSN04194A1 (fr) | Derives de tropane servant de modulateurs de ccr5 | |
PE20060957A1 (es) | Compuestos pirazolopiridinas su preparacion y composiciones farmaceuticas | |
NO20060146L (no) | Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav | |
CL2003002565A1 (es) | Compuestos derivados de 3h-quinazolin-4-ona, su proceso de preparacion, composicion farmaceutica que los contiene, y uso en el tratamiento y prevencion de enfermedades mediadas por inhibidores de mao-b, tales como la enfermedad de alzheimer y demenci | |
PE20060869A1 (es) | Sulfonamido-macrociclos y sus sales como inhibidores de tie2 y composiciones farmaceuticas que comprenden estos compuestos | |
NO20051958L (no) | Forbindelser | |
PE20010485A1 (es) | Derivados de bencimidazol sustituidos con aminocarbonilo, procedimiento para su preparacion y su utilizacion como medicamentos | |
CO6150168A2 (es) | Combinaciones farmacologicas que comprenden benzoxazinonas para el tratamiento de enfermedades de las vias aereas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |